FDA accepts Sangamo BioSciences’ IND for SB-BCLmR-HSPC genome editing approach

Posted in: Device / Technology News | Medical Condition News

Tags: AIDS, Alzheimer’s Disease, Anemia, Beta-Thalassemia, Blood, Bone, Bone Marrow, Bone Marrow Transplant, CDC, Cell, Chelation Therapy, Clinical Trial, DNA, Gene, Genes, Genetic, Hemoglobin, Hemophilia, HIV, HIV/AIDS, Hospital, Huntington’s Disease, Infectious Diseases, Protein, Sickle Cell Disease, Stem Cell, Thalassemia, Transplant